688314.SH
康拓医疗
SSE · Healthcare · Medical - Devices · CN
CNY 30.76
−5.03%Year over year
Reported trailing growth
- Revenue
- +2.3%
- EBITDA
- —
- EBIT
- -14.1%
- EPS
- -5.5%
- Free cash flow
- -32.0%
- Operating cash flow
- -9.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +13.5%
- EBITDA
- +8.3%
- EBIT
- +8.7%
- Net income
- +9.3%
- EPS
- +9.2%
- Free cash flow
- -3.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026